PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

GLP-1 drugs used for weight loss involve all kinds of side effects ... include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and Zepbound (tirzepatide).) ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, ...

The risks of 'miracle' weight loss jabs such as Ozempic, Wegovy and Mounjaro have been laid bare by a landmark study ...